Application Deadline U.S. citizens: 2025-26 Fulbright U.S. Scholar Competition Deadline is Monday, September 16, 2024 at 5 PM EST. Find out more.
Home Country Egypt Ex Vivo and Vivo Evaluating the Anti-pancreatic Cancer Efficacy of Novel Nanoformulation of Diethyldithiocarbamate-cuprous Oxide: Targeting Cancer Stem Cells and Stellate Cells Program Fulbright Visiting Scholar Program Program Country Egypt Grant Activity Type Research Discipline Medical Sciences Specialization Biomedical Sciences Academic Year 2022-2023 Dates September 2022 - May 2023 Flex No Scholar type Non-U.S. (Visiting) Scholar Project Title Ex Vivo and Vivo Evaluating the Anti-pancreatic Cancer Efficacy of Novel Nanoformulation of Diethyldithiocarbamate-cuprous Oxide: Targeting Cancer Stem Cells and Stellate Cells Scholar Information Grantee Marwa Muhammad Abuserie Ali Title Associate Professor Institution City of Scientific Research and Technological Applications (SRTA-City) Egypt Host Institutions Institution University of Alabama, Birmingham Faculty Vikas Dudeja
Ex Vivo and Vivo Evaluating the Anti-pancreatic Cancer Efficacy of Novel Nanoformulation of Diethyldithiocarbamate-cuprous Oxide: Targeting Cancer Stem Cells and Stellate Cells Program Fulbright Visiting Scholar Program Program Country Egypt Grant Activity Type Research Discipline Medical Sciences Specialization Biomedical Sciences Academic Year 2022-2023 Dates September 2022 - May 2023 Flex No Scholar type Non-U.S. (Visiting) Scholar Project Title Ex Vivo and Vivo Evaluating the Anti-pancreatic Cancer Efficacy of Novel Nanoformulation of Diethyldithiocarbamate-cuprous Oxide: Targeting Cancer Stem Cells and Stellate Cells Scholar Information Grantee Marwa Muhammad Abuserie Ali Title Associate Professor Institution City of Scientific Research and Technological Applications (SRTA-City) Egypt Host Institutions Institution University of Alabama, Birmingham Faculty Vikas Dudeja